By mimicking key features of the IDH-mut phenotype, such as increased radiosensitivity and altered expression of therapeutic targets, 2HG or its downstream pathways may offer promising avenues for the development of novel, targeted therapies in IDH-wt gliomas. The gene discussed is IDH1; the disease is glioma.